Wikipedia

Gynaecology

(Redirected from Gynecologic condition)
For the book by Mary Daly, see Gyn/Ecology.

Gynaecology or gynecology (see American and British English spelling differences) is the area of medicine concerned with conditions affecting the female reproductive system. It is sometimes combined with the field of obstetrics, which focuses on pregnancy and childbirth, thereby forming the combined area of obstetrics and gynaecology (OB-GYN).[1]

Gynaecology
SystemFemale reproductive system
SubdivisionsGynaecological oncology, maternal and fetal medicine, reproductive medicine and urogynaecology
Significant diseasesGynaecological cancers, infertility, dysmenorrhea, polycystic ovary syndrome, endometriosis
Significant testsHysteroscopy, laparoscopy, hormone levels, pap smear, HPV
SpecialistGynaecologist

Gynaecology encompasses preventative care, sexual health and diagnosing and treating health issues arising from the female reproduction system, such as the uterus, vagina, cervix, fallopian tubes, ovaries, and breasts; subspecialties include family planning; minimally invasive surgery; pediatric and adolescent gynecology; and pelvic medicine and reconstructive surgery.

While gynaecology has traditionally centered on women, it increasingly encompasses anyone with female organs,[2] including transgender, intersex, and nonbinary individuals; however, many men face accessibility issues due to stigma, bias, and systemic exclusion in healthcare.[3]

Etymology

edit

The word gynaecology comes from the oblique stem (γυναικ-) of the Greek word γυνή (gyne) meaning 'woman', and -logia meaning 'study'.[4] Literally translated, it means 'the study of women'.[5][6] Its counterpart is andrology, which deals with medical issues specific to the male reproductive system.[7]

History

edit

Antiquity

edit

The Kahun Gynaecological Papyrus, dated to about 1800 BC, deals with gynecological diseases, fertility, pregnancy, contraception, etc. The text is divided into thirty-four sections, each dealing with a specific problem and containing diagnosis and treatment; no prognosis is suggested. Treatments are non-surgical, consisting of applying medicines to the affected body part or delivering medicines orally. During this time, the womb was sometimes seen as the source of problems manifesting in other body parts.[8]

Ayurveda, an Indian traditional medical system, also provides details about concepts and techniques related to gynaecology, addressing fertility, childbirth complications, and menstrual disorders among other things.[9][10] These writings provide a post and prenatal care, integrating lifestyle practices, meditations and yoga, and a dietary regime for overall well-being.

The Hippocratic Corpus contains several gynaecological treatises dating to the 5th and 4th centuries BC. Aristotle is another source for medical texts from the 4th century BC with his descriptions of biology primarily found in History of Animals, Parts of Animals, Generation of Animals.[11] The gynaecological treatise Gynaikeia by Soranus of Ephesus (1st/2nd century AD) is extant (together with a 6th-century Latin paraphrase by Muscio, a physician of the same school). He was the chief representative of the school of physicians known as the "methodists."

Middle ages and renaissance period

edit

During the Middle Ages, unqualified midwives dominated women's health concerns through experienced-based knowledge, traditional remedies, and herbal medicines. Midwifery was often regarded unscientific and was challenged with the rise of gynecology as an official medical field. The Renaissance period, 16th century, brought about a resurgence of classical scientific advancements, including the rise of medical advancements in the field of gynecology and obstetrics. Figures like Ambroise Pare were imperative in improving obstetrics techniques during this period. Peter Chamberlen developed the forceps, an important surgical tool that transformed childbirth and lessened maternal mortality.[12]

18th, 19th and 20th centuries

edit

As medical institutions continued to expand in the 18th-19th centuries, the authority of midwives was challenged by men who dominated medical professions.[13] The formalization of midwifery training by male doctors and advancements in medical knowledge of women's health and anatomy occurred during this period. Figures such as William Smellie, William Hunter, Paul Zweifel, Franz Karl Naegele, and Carl Crede contributed to the understanding of childbirth and women's health in Europe.[12]

In the early 18th and 19th centuries, in the United States, the field of gyneacology, as with most medical specialities, had ties to black women and therefore slavery. Brothers Henry and Robert Campbell were editors of the first medical journal in the deep south. Henry worked as gynaecologist including on enslaved women, whilst publishing medical case narratives of operations in the journal the brothers edited. This created a conflict of interest.[13] Others, such as Dr. Mary Putnam Jacobi, challenged the exclusion of women from medical education and shifted gynaecology to a scientific practice.[14]

J. Marion Sims is regarded as the father of modern gynecology.[15] Some of his medical contributions were published, such as development of the Sims' position (1845), the Sims' speculum (1845), the Sims’ sigmoid catheter, and gynecological surgery. He was the first to develop surgical techniques for the repair of vesico-vaginal fistulas (1849), a consequence of protracted childbirth which at the time was without treatment. He founded the first women's hospital in the country in Alabama 1855 and subsequently the Woman's Hospital of New York in 1857. He was elected president of the American Medical Association in 1876. Sims died in 1883.[16] His statue was removed from Central Park, after a unanimous vote in 2018.[17]

Sims’ legacy is controversial and debated as he conducted experimental operations on black enslaved women, as recounted in his autobiography.[18][19] In this era, anesthesia use was novice and considered dangerous. Sims developed his techniques and instruments by operating on women, without anesthesia.[20][21] The ethical issues this created are discussed in the Journal of Medical Ethics and by academic scholars, some of whom have different opinions in regards to consent and why anesthesia was not used, whilst showing that white women were also subject to experimental procedures.[22][23] When he left Alabama in 1853, a local newspaper called him "an honor to our state."[24]

In terms of common procedures used within the now recognised specialism of gynaecology, the first hysteroscopy was completed in 1869 by Pantaleoni, to treat an endometrial polyp, using a cystoscope.[25]

Obstetrics and gynaecology were recognised as specialties in the mid-19th century, in the United Kingdom. Specialist societies came into being but it became clear that to become disciplines in their own right a separate college was required. William Fletcher Shaw (Professor of Midwifery at Manchester University) and William Blair-Bell (Professor of Obstetrics at Liverpool University) worked to establish The British College of Obstetricians and Gynaecologists in 1929[26], this later became the Royal College of Obstetricians and Gynaecologists.[27]

George Nicholas Papanicolaou, from Greece, is credited with discovering the pap smear test, he identified differences in the cytology of normal and malignant cervical cells by viewing swabs smeared on microscopic slides. His first publication of the finding in 1928 went relatively unnoticed. It wasn't until he collaborated with Dr Herbert Traut at an American hospital and they published a book, Diagnosis of Uterine Cancer by the Vaginal Smear that this medical advancement became widely known about.[28] By the 20th century, the American College of Obstetricians and Gynecologists (1951) was founded. There were advances in antiseptic techniques, anesthesia, and diagnostic tools, which transformed gynaecological care.[29]

Some discrimination continued in the United States with forced sterilizations and eugenic policies that disproportionately targeted minorities. In addition to black women, coerced sterilisation was used as a method to restrict perceived undesirable groups from reproducing, such as immigrants, poor people, unmarried mothers, disabled and mentally ill people.[30] Between 1909 and 1979, an estimated 20,000 forced sterilizations occurred in California, primarily in state run mental institutions and prisons.[31] Healthcare later became more focused on the importance of informed consent.[32] Since the 1950's an emphasis on a patients right to choose whether to have treatment or not has existed, albeit with a reliance on those with medical knowledge to advise the best course of treatment. Technological advances have in more recent decades enabled patients themselves to obtain media information more easily.[33]

In Canada, The Royal College of Physicians and Surgeons did not formally recognise obstetrics & gynecology as specialist fields until 1957.[34] Obstetrics and gynaecology were considered part of the division of surgery. During the 1940's, practitioners focused on obstetrics and gynaecology began identifying the need for a separate organization to deal with this specialism and the idea to form the Society of Obstetricians and Gynaecologists of Canada (SOGC) was conceived.[35]

Ian Donald, a gynaecologist from the United Kingdom was an early pioneer of the use of sonography within gyneacology and obstetrics. He gained knowledge of radar technology in the air force and working with an engineer called Tom Brown and an engineering company, they developed a compact 2D ultrasound machine. In 1958, he published a paper in the Lancet.[36]

Birth control trials

edit
Main article: Contraceptive trials in Puerto Rico
See also: Gregory G. Pincus

Women like Margaret Sanger dedicated themselves to making contraception legal and available. She had worked as a nurse caring for women who had illegal abortions, this created a desire to engage in later activism related to birth control. In 1951 she met Gregory Pincus, a human reproduction medical expert who worked to create a contraceptive pill. She also found a sponsor for the project and trials, Katharine McCormick.[37]

The trials for birth control were controversial for a number of reasons. In 1954, due to anti-birth control laws, the first trials in Massachusetts were positioned as being fertility trials. Gregory Pincus and John Rock conducted these trials. Oral progesterone was tested on fertility patients, with consent, however the oral contraceptive was also tested on 28 psychiatric patients (male and female) at Worcester State Hospital. No direct consent was given by these people, instead relatives gave consent on their behalf. They discovered that women stopped ovulating and that this occurred only whilst taking this. To get FDA approval, a larger clinical trial was needed.[38]

To expand this research, further clinical trials of took place in Puerto Rico, a territory of the United States. Puerto Rico was densely populated with significant poverty, had no anti-birth control laws and already had services offering birth control. Trials began in Rio Piedras in 1956, and women were offered the pill, called Envoid in 1960, on the basis it prevented pregnancy but without knowing it did not have FDA approval. Three women died in the trial and criticisms include that side effects were not taken as seriously as they should have been.[39][40][41] Dr. Edris Rice-Wray, a professor at the Puerto Rico Medical School was aware and vocal of the negative side effects of the pill.[42] Although these trials did not follow modern medical ethical practices, they spearheaded the development of the first oral contraceptive.

Diagnosis

edit
 
The historic taboo associated with the examination of female genitalia has long inhibited the science of gynaecology. This 1822 drawing by Jacques-Pierre Maygrier shows a "compromise" procedure, in which the physician is kneeling before the woman but cannot see her genitalia. Modern gynaecology no longer uses such a position.[43]

In some countries or within some healthcare systems, women must first see a general practitioner or family practitioner before seeing a gynaecologist. If the condition cannot be diagnosed or treated and requires a specialist the patient is referred to a gynaecologist.[44] In other countries, patients can see a gynaecologist without a referral.[45]

As with all of medicine, the main tools of diagnosis are clinical history, examination and investigations.[46] Gynaecological examination is quite intimate, more so than a routine physical exam. It can also require instruments such as the speculum. The speculum is used to retract the tissues of the vagina to allow examination of the cervix, the lower part of the uterus located within the upper portion of the vagina. Gynaecologists may do a bimanual examination (one hand on the abdomen and one or two fingers in the vagina) to palpate the cervix, uterus, ovaries and pelvis.[47] It is not uncommon to do a rectovaginal examination for a complete evaluation of the pelvis, particularly if any suspicious masses are suspected. Gynaecologists may have a chaperone for their examination or a patient can request this.

An abdominal or vaginal ultrasound can be used for diagnostic purposes. This can help to detect growths, such as polyps, endometrial hyperplasmia, carcinoma, endometriosis, pelvic inflammatory disease, polycystic ovary syndrome and many other gynaecology conditions. This is a very common diagnostic tool.[48]

Hormone tests can be useful when investigating gynaecology based conditions or symptoms. These may check the hormone levels of oestradiol, progesterone, follicle stimulating hormone and luteinizing hormones, for example. Levels considered not normal, could indicate the presence of conditions and could impact reproductive function.[49]

Conditions and diseases

edit
Main article: Female genital disease

Examples of conditions dealt with by a gynaecologist are:

Some of these conditions are dealt with by doctors with specialisms other than, or in addition to, gynaecology. For example, a woman with urinary incontinence may be referred to a doctor with urology specialist experience[63] and someone with cancer may be treated by a multidisciplinary team with specialist oncology experience.[64]

Treatments

edit

Surgeries

edit

Gynaecologists may employ medical and/or surgical treatments, depending on the medical condition they are treating. Pre- and post-operative medical management often employs drug therapies, such as antibiotics, diuretics, antihypertensives, and antiemetics. Additionally, gynaecologists make frequent use of specialized hormone-modulating therapies (such as Clomifene citrate and hormonal contraception) to treat disorders of the female genital tract that are responsive to pituitary or gonadal signals.

For lists of gynaecological drugs (by the ATC classification system), see ATC code G01 and ATC code G02.

Surgery is commonly used to treat gynaecology conditions. In the past, gynaecologists were not considered "surgeons", although this point has always been the source of controversy. Modern advancements in general surgery and gynaecology, have blurred the lines of distinction. The rise of sub-specialties within gynaecology which are primarily surgical in nature (for example urogynaecology and gynaecological oncology) have strengthened the reputations of gynaecologists as surgical practitioners, and many surgeons and surgical societies have come to view gynaecologists as peers. Gynaecologists are now eligible for fellowship in both the American College of Surgeons and Royal Colleges of Surgeons, and many newer surgical textbooks include chapters on (at least basic) gynaecological surgery.

Some of the more common operations that gynaecologists perform include:[65]

  1. Dilation and curettage (removal of the uterine contents for various reasons, including completing a partial miscarriage and diagnostic sampling for dysfunctional uterine bleeding refractive to medical therapy)[66]
  2. Polypectomy (removal of polyps)[67]
  3. Hysterectomy (removal of the uterus)[68]
  4. Oophorectomy (removal of the ovaries)
  5. Myomectomy (removal of fibroids)[69]
  6. Endometrial ablation (destroys layer of the endometrium to reduce bleeding)[70]
  7. Tubal ligation (a type of permanent sterilization)[71]
  8. Hysteroscopy (inspection of the uterine cavity)[72]
  9. Laparoscopy – minimally invasive surgery used to diagnose or treat a variety of conditions.[73] Laparoscopy can accurately diagnose pelvic/abdominal endometriosis,[74] more recently non-operative methods have been used for endometriosis diagnosis[75]
  10. Laparotomy – may be used to investigate the level of progression of benign or malignant disease, or to assess and repair damage to the pelvic organs[76][77]
  11. Various surgical treatments for urinary incontinence and pelvic prolapse, including mid-urethral mesh sling procedures[78]
  12. Appendectomy – often performed to remove site of painful endometriosis implantation or prophylactically (against future acute appendicitis) at the time of hysterectomy or Caesarean section. May also be performed as part of a staging operation for ovarian cancer.
  13. Cervical Excision Procedures (including cryosurgery) – removal of the surface of the cervix containing pre-cancerous cells which have been previously identified on Pap smear.

Non-surgical treatments

edit

Tranexamic acid has been found to be an effective drug to reduce the amount of bleeding during menstruation and medical procedures, so can be used to treat menorrhagia.[79] Hormone based IUDs, such as Mirena have also been shown to help reduce heavy periods.[80]

There are an increasing number of non-surgical treatments available to help uterine fibroids, along with tranexamic acid and progesterone releasing IUSs, such as contraceptive steroid hormones, gonadotropin releasing hormone (GnRH) agonists and antagonists with and without additional hormones, and selective progesterone receptor modulator (SPRM). Organisations such as the American College of Obstetricians and Gynecologists (ACOG) advocate such treatments before surgical intervention, but studies reveal many women who had a hysterectomy between 2011 and 2019 did not receive any other treatments before this.[81]

Hormonal therapy can be used as a non-surgical treatment for endometriosis. Research shows gonadotropin-releasing hormone (GnRH) antagonists, like elagolix, can give encouraging results in managing some symptoms. Also encouraging is research on aromatase inhibitors, such as letrozole that has shown efficacy in reducing lesion size and pain severity.[82] Overall, more recent research shows a trend of new non-surgical treatments becoming available for a number of common gynaecology conditions.

Recent discoveries

edit

Newer advancements in gynaecology are using integration of artificial intelligence (AI) in clinical practice, specifically with diagnostics and predictive analytics. AI algorithms are able to interpret complex gynecological imaging and pathology data, which improves diagnostic accuracy. These technologies are especially used in identifying cervical and ovarian cancers and predicting treatment outcomes.[83]

Liquid biopsy is emerging as an important noninvasive tool to detect and monitor gynaecology cancers. Tumor-derived biomarkers, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and microRNA, can provide insights into the biological behavior of gynaecology cancers. Some believe this could revolutionise cancer treatment, assisting with earlier detection and predicting disease recurrence but as of 2025, it is not widely used in clinical practice.[84]

In terms of surgery, research has led to minimally invasive approaches, such as vaginal natural orifice transluminal endoscopic surgery. This technique allows surgeons to access the pelvic cavity through the vaginal canal, reducing recovery times, postoperative pain, and complication rates in comparison to traditional methods.[85]

Specialist training

edit
Gynaecologist
Occupation
Names
  • Physician
  • Surgeon
Occupation type
Specialty
Activity sectors
Medicine, Surgery
Description
Education required
Fields of
employment
Hospitals, Clinics

In the United Kingdom, the Royal College of Obstetricians and Gynaecologists, based in London, encourages the study and advancement of both the science and practice of obstetrics and gynaecology. This is done through postgraduate medical education and training development, and the publication of clinical guidelines and reports on aspects of the specialty and service provision. The RCOG International Office works with other international organisations to help lower maternal morbidity and mortality in under-resourced countries.[86]

In the United States, obstetrics and gynecology requires residency training for four years. This encompasses comprehensive clinical and surgical education. OBGYN residents participate in a yearly in-training exam that is administered by the Council on Resident Education in Obstetrics and Gynecology (CREOG). Research suggests that combining curriculum and focused mentorship can improve residents' performance on the exam and overall educational outcomes.[87]

Gynaecologic oncology is a subspecialty of gynaecology, dealing with gynaecology-related cancer.[88] To become a gynaecology oncologist requires specialist further training.[89] Urogynaecology is also a subspecialty of gynaecology and urology.[63] Further fellowship training is needed to become a urogynaecologist.[90]

Gender of physicians

edit

Improved access to education and the professions in recent decades has seen women gynaecologists outnumber men in the once male-dominated medical field of gynaecology.[91] In some gynaecological sub-specialties, where an over-representation of males persists, income discrepancies appear to show male practitioners earning higher averages.[92]

Speculations on the decreased numbers of male gynaecologist practitioners report a perceived lack of respect from within the medical profession, limited future employment opportunities and questions to the motivations and character of men who choose the medical field concerned with female sexual organs.[93][94][95][96][97]

Surveys of women's views on the issue of male doctors conducting intimate examinations show a large and consistent majority found it uncomfortable, were more likely to be embarrassed and less likely to talk openly or in detail about personal information, or discuss their sexual history with a man. The findings raised questions about the ability of male gynaecologists to offer quality care to patients.[98] This, when coupled with more women choosing female physicians[99] has decreased the employment opportunities for men choosing to become gynaecologists.[100]

In the United States, it has been reported that four in five students choosing a residency in gynaecology are now female.[101] In several places in Sweden, to comply with discrimination laws, patients may not choose a doctor—regardless of specialty—based on factors such as gender and declining to see a doctor because of their gender may legally be viewed as refusing care.[102][103] In Turkey, due to patient preference to be seen by another female, there are now few male gynaecologists working in the field.[104]

There have been a number of legal challenges in the US against healthcare providers who have started hiring based on the gender of physicians. Mircea Veleanu argued, in part, that his former employers discriminated against him by accommodating the wishes of female patients who had requested female doctors for intimate exams.[105] A male nurse complained about an advert for an all-female obstetrics and gynaecology practice in Columbia, Maryland, claiming this was a form of sexual discrimination.[106] In 2000, David Garfinkel, a New Jersey-based OB-GYN, sued his former employer[107] after being fired due to, as he claimed, "because I was male, I wasn't drawing as many patients as they'd expected".[105]

Health disparities in gynecology

edit
See also: Gynecologic cancer disparities in the United States

Subsequent to research, some organisations such as the Royal College of Obstetricians and Gynaecologists have called on global governments and international health bodies to address the impact of benign gynaecology conditions in low and middle income countries. They found the years lost to disability from these conditions was greater than combined morbidity from malaria, TB and HIV/AIDS, accounting for 8% of all years lost to disability, for women aged 15-49. They argue that such conditions are neglected within the global health arena and have a significant impact on women in low and middle income countries.[108]

Some benign and common gynaecology conditions have been found to disproportionately impact certain racial and ethnic groups. One study found that black women are three times more likely than white women, to have uterine fibroids, a variety of studies found they are more likely to get these at a younger age are more likely to have numerous and rapid growing fibroids. This may be due to biological, lifestyle, environmental and clinical factors, further research is needed to understand why this disparity exists. In regards to endometriosis, some research suggests this disproportionately impacts asian women, with black and hispanic women less likely to have this condition. Research about this is somewhat inconsistent suggesting further studies would be beneficial.[109]

In the United States, health disparities persist in gynecology, disproportionately affecting women of color, low-income women, and those living in rural areas.[110] Black women face higher rates of mortality from some gynaecology based cancers. The reasons for these disparities is complex and involves racial, economic, educational and geographic factors that influence treatment and survival. Importantly, a variation from evidenced-based treatment has been indicated as a modifiable factor that can effect survival outcomes. This problem disproportionately impacts black women and poorer women. These disparities are compounded by barriers such as lack of insurance and best practice not being followed, particularly when funded by Medicaid.[111]

Some research in the United States shows that hispanic women had a more favorable prognosis compared to non-hispanic women, in regards to certain gynaecology based cancers. With ovarian cancer black women tended to present with more advanced ovarian cancer compared to white women, so were diagnosed at a later stage. The incidence rates of endometrial and ovarian cancer was highest in white women and the incidence of cervical cancer was highest in black women. Research showed that black and hispanic women were less likely to complete the full number of HPV vaccinations, the cause of some gynaecology based cancers.[111] Marginalized groups are less likely to have their pain and symptoms taken seriously by providers, leading to delayed diagnoses and worse outcomes.[112] Addressing these disparities requires having physicians practice cultural humility and physician's addressing their possible bias.[110]

Research from the United States shows that disabled women are screened less for cervical cancer and less likely to have pelvic examinations. They report lower levels of receiving family planning services. Health service usage and whether or not they have insurance did not explain differences in screening levels. Research showed they were less likely to receive doctors recommendations.[113] Women with disabilities also have a greater chance of dying from cervical cancer in counties such as South Korea and Sweden.[114]

In the United Kingdom, in regards to ovarian cancer socioeconomic factors appear to create a disparity in treatment and outcomes. Delays and treatment inequalities may contribute to worse outcomes for women from more deprived areas, with them less likely to receive surgery or chemotherapy. How wealthy a woman is, directly impacted mortality rates.[115] Cervical screening attendance, which helps to diagnose cervical cancer at an early stage has declined, particularly among minority ethnic groups and in more deprived areas. Medical bias in doctor and patient interactions can cause delays to diagnosis and can stem from subconscious stereotypes, in relation to ethnicity or socioeconomic status.[116]

The LGBTQ+ community also face health disparities within gyneacology care. Nearly one in five lesbian and bisexual women have never attended cervical screening. Transexual men and non binary people with a cervix are also less likely to access cervical screening.[117] Research has shown that 22.8% of transgender people avoid accessing healthcare due to anticipated discrimination.[118] Gyneacologists play an important role in caring for transgender patients, who face barriers within health care, as a result of marginalization and discrimination.[119]

Indigenous women in Australia are more likely to die from gynaecology cancers. Research suggests that strategies to reduce survival disparities should target earlier diagnosis and earlier treatment, as aboriginal women were more likely to present with more advanced cancer at the point of diagnosis and decline treatment.[120] Research in Australia examined the issue of pelvic floor dysfunction in aboriginal women, in New South Wales. This showed a high burden of disease and that there was a reluctance of these women to seek care, due to fear of judgement and embarrassment. The authors concluded that culturally appropriate and tailored care was needed to tackle this.[37]

See also

edit

References

edit
  1. ^ "Obstetrics and gynecology". www.cancer.gov. 2 February 2011. Retrieved 28 February 2025.
  2. ^ Ratini, Melinda (ed.). "What Is a Gynecologist?". WebMD. Retrieved 7 June 2025.
  3. ^ "Ethics in obstetric and gynaecologic care for transgender and non-binary individuals | Figo". www.figo.org. 14 November 2024. Retrieved 18 August 2025.
  4. ^ "gynecology". Academic Dictionaries and Encyclopedias. Archived from the original on 25 September 2022. Retrieved 26 April 2022.
  5. ^ Porter, Roy (July 1991). "Ornella Moscucci, The science of women: gynaecology and gender in England, 1800–1929, Cambridge History of Medicine, Cambridge University Press, 1990, 8vo, pp. x, 278, illus., £35.00, $49.50". Medical History. 35 (3): 372. doi:10.1017/S0025727300054004.
  6. ^ McGill, Markus (29 August 2017). "Gynecologists: When to see one, what to expect, common procedures". Medical News Today. Archived from the original on 21 May 2022. Retrieved 23 April 2022.
  7. ^ Sadri-Ardekani, Hooman; Atala, Anthony (2019). "Regenerative Medicine for the Male Reproductive System". Principles of Regenerative Medicine. pp. 1251–1261. doi:10.1016/B978-0-12-809880-6.00071-0. ISBN 978-0-12-809880-6.
  8. ^ Dixon, Laurinda S. (1995). Perilous Chastity: Women and Illness in Pre-Enlightenment Art and Medicine. Cornell University Press. p. 15f. ISBN 978-0-8014-3026-8.
  9. ^ S. V. Govindan (November 2002). Fundamental Maxims of Ayurveda: Prepared for the Common People. Abhinav Publications. pp. 142–143. ISBN 978-81-7017-417-2. Archived from the original on 9 July 2020. Retrieved 23 June 2020.
  10. ^ Islam, Md. Nazrul (2017). Chinese and Indian Medicine Today. p. 134. doi:10.1007/978-981-10-3962-1. ISBN 978-981-10-3961-4.
  11. ^ Dean-Jones, Lesley (2003). "The Cultural Construct of the Female Body in Classical Greek Science". Sex and Difference in Ancient Greece and Rome. pp. 183–201. doi:10.1515/9781474468541-014. ISBN 978-1-4744-6854-1.
  12. ^ a b Oyelese, Yinka; Grünebaum, Amos; Chervenak, Frank (1 November 2024). "Respect for history: an important dimension of contemporary obstetrics and gynecology". Journal of Perinatal Medicine. 52 (9): 914–926. doi:10.1515/jpm-2024-0348. ISSN 1619-3997. PMID 39272109.
  13. ^ a b Owens, Deirdre Cooper (2017). Medical Bondage Race, Gender, and the Origins of American Gynecology. Athens: University of Georgia Press (published 15 November 2017). pp. 15–18. ISBN 9780820353036.
  14. ^ Morantz-Sanchez, R. (1985). Sympathy and Science: Women Physicians in American Medicine. Oxford University Press.
  15. ^ Semple, Henry Churchill (1923). J. Marion Sims, the Father of Modern Gynecology. Archived from the original on 11 June 2020. Retrieved 11 October 2013.
  16. ^ "James Marion Sims (1813-1883) | Embryo Project Encyclopedia". embryo.asu.edu. Retrieved 24 March 2025.
  17. ^ "New York: James Marion Sims statue removed from Central Park". 17 April 2018. Retrieved 22 August 2025.
  18. ^ "The story of my life". Library of Congress, Washington, D.C. 20540 USA. Retrieved 24 March 2025.
  19. ^ Cooper Owens, Deirdre Benia (2018). Medical bondage: race, gender, and the origins of American gynecology (Paperback ed.). Athens: The University of Georgia Press. ISBN 978-0-8203-5475-0.
  20. ^ Russ, Joanna; Daly, Mary (1979). "Gyn/Ecology: The Metaethics of Radical Feminism". Frontiers: A Journal of Women Studies. 4 (1): 68. doi:10.2307/3346672. ISSN 0160-9009. JSTOR 3346672.
  21. ^ Adekunle, Julius O.; Williams, Hettie V., eds. (2010). Color Struck. Hamilton. doi:10.5771/9780761850922. ISBN 978-0-7618-5092-2.
  22. ^ Wall, L L (26 May 2006). "The medical ethics of Dr J Marion Sims: a fresh look at the historical record". Journal of Medical Ethics. 32 (6): 346–350. doi:10.1136/jme.2005.012559. ISSN 0306-6800. PMC 2563360. PMID 16731734.
  23. ^ Ojanuga, D (March 1993). "The medical ethics of the 'father of gynaecology', Dr J Marion Sims". Journal of Medical Ethics. 19 (1): 28–31. doi:10.1136/jme.19.1.28. ISSN 0306-6800. PMC 1376165. PMID 8459435.
  24. ^ "Medical Journals". Sumter County Whig. Livingston, Alabama. 22 March 1854. p. 2. Archived from the original on 18 June 2022. Retrieved 18 June 2022 – via newspapers.com.
  25. ^ Moore, Jessica F.; Carugno, Jose (6 April 2025), "Hysteroscopy", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 33232015, retrieved 19 August 2025
  26. ^ "O&G pre-20th century and foundation of the College". RCOG. Retrieved 18 August 2025.
  27. ^ "A Royal College for the 21st century". RCOG. Retrieved 18 August 2025.
  28. ^ Tan, Siang Yong; Tatsumura, Yvonne (October 2015). "George Papanicolaou (1883-1962): Discoverer of the Pap smear". Singapore Medical Journal. 56 (10): 586–587. doi:10.11622/smedj.2015155. ISSN 2737-5935. PMC 4613936. PMID 26512152.
  29. ^ Briggs, L. (2002). Reproducing Empire: Race, Sex, Science, and U.S. Imperialism in Puerto Rico. University of California Press.
  30. ^ Ko, Lisa. "Unwanted Sterilization and Eugenics Programs in the United States". Independent Lens. Retrieved 18 August 2025.
  31. ^ Loeb, Charles A.; Lavold, Abigail; Pardini-Furtado, Thiago; Bash, Jasper C.; Andino, Juan; Mills, Jesse N. (May 2024). "Hf01-02 Forced Sterilization in California: A Haunting Past and Persistent Inequity". The Journal of Urology. 211 (5S). doi:10.1097/01.JU.0001008828.35887.de.02.
  32. ^ Hossein Rashidi, Batool; Heidary, Zohreh; Akhlaghi, Mitra; Moosavi, Farinaz; Hivechi, Nafiseh; Saeedinia, Mohsen; Ghaemi, Marjan (March 2023). "Pros and Cons of Informed Consent in Gynecology and Obstetrics". Iranian Journal of Medical Sciences. 48 (2): 227–228. doi:10.30476/IJMS.2022.96071.2757. ISSN 1735-3688. PMC 9989236. PMID 36895453.
  33. ^ Kilbride, Madison K.; Joffe, Steven (20 November 2018). "The New Age of Patient Autonomy: Implications for the Patient-Physician Relationship". JAMA. 320 (19): 1973–1974. doi:10.1001/jama.2018.14382. ISSN 1538-3598. PMC 6988779. PMID 30326026.
  34. ^ "Our History | Department of Obstetrics and Gynecology". www.ualberta.ca. Retrieved 19 August 2025.
  35. ^ Mitchell, Bryan F. (December 2019). "The Evolution of Obstetrics and Gynaecology and Related Subspecialties in Canada". Journal of Obstetrics and Gynaecology Canada. 41: S224 – S226. doi:10.1016/j.jogc.2019.08.021. ISSN 1701-2163. PMID 31785661.
  36. ^ Campbell, S. (2013). "A short history of sonography in obstetrics and gynaecology". Facts, Views & Vision in ObGyn. 5 (3): 213–229. ISSN 2032-0418. PMC 3987368. PMID 24753947.
  37. ^ a b Brown, Kiarna; Clarke, Marilyn (20 June 2023). "First Nations women's health 2023". Australian and New Zealand Journal of Obstetrics and Gynaecology. 63 (3): 275–277. doi:10.1111/ajo.13687. ISSN 1479-828X. PMID 37340604.
  38. ^ "The Boston Pill Trials". www.pbs.org. Retrieved 22 August 2025.
  39. ^ "Lights and Shadows of US Birth Control Testing in Puerto Rico: History and Implications for Other Latin American Countries". Johns Hopkins SAIS. 10 February 2022. Retrieved 5 April 2025.
  40. ^ Blakemore, Erin (9 May 2018). "The First Birth Control Pill Used Puerto Rican Women as Guinea Pigs". HISTORY. Retrieved 5 April 2025.
  41. ^ "The Puerto Rico Pill Trials | American Experience". www.pbs.org. Retrieved 5 April 2025.
  42. ^ Lenharo, Mariana (24 April 2024). "Las Borinqueñas remembers the forgotten Puerto Rican women who tested the first pill". Nature. 629 (8010): 32–33. Bibcode:2024Natur.629...32L. doi:10.1038/d41586-024-01175-5. PMID 38658720.
  43. ^ Modesty, Medical Patient. "History of Modern Gynecology". patientmodesty.org. Archived from the original on 26 February 2025. Retrieved 13 April 2025.
  44. ^ "Referrals for specialist care". nhs.uk. 5 November 2020. Retrieved 22 August 2025.
  45. ^ "What Does a Gynecologist Do?". Cleveland Clinic. Retrieved 22 August 2025.
  46. ^ Balogh, Erin P.; Miller, Bryan T.; Ball, John R.; Care, Committee on Diagnostic Error in Health; Services, Board on Health Care; Medicine, Institute of; The National Academies of Sciences, Engineering (29 December 2015), "The Diagnostic Process", Improving Diagnosis in Health Care, National Academies Press (US), retrieved 13 April 2025
  47. ^ Long, W. Newton (1990), Walker, H. Kenneth; Hall, W. Dallas; Hurst, J. Willis (eds.), "Pelvic Examination", Clinical Methods: The History, Physical, and Laboratory Examinations (3rd ed.), Boston: Butterworths, ISBN 978-0-409-90077-4, PMID 21250129, retrieved 13 April 2025
  48. ^ Karena, Zalak V.; Mehta, Aditya D. (2025), "Sonography Female Pelvic Pathology Assessment, Protocols, and Interpretation", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 36251809, retrieved 13 April 2025
  49. ^ "Reproductive hormones - Best Tests". bpac.org.nz. February 2013. Retrieved 22 August 2025.
  50. ^ CDC (12 September 2024). "Gynecologic Cancers Basics". Gynecologic Cancers. Retrieved 19 August 2025.
  51. ^ "Female Urinary Incontinence". Australian Urology Associates. Retrieved 19 August 2025.
  52. ^ "Amenorrhoea". The National Institute for Health and Care Excellence. Retrieved 19 August 2025.
  53. ^ "Uterine Fibroids or Polyps? Symptoms, Diagnosis, & Treatment". eMedicineHealth. Retrieved 19 August 2025.
  54. ^ "Endometriosis - Symptoms and causes". Mayo Clinic. Retrieved 19 August 2025.
  55. ^ "Painful periods (dysmenorrhoea)". www.healthdirect.gov.au. 3 March 2025. Retrieved 19 August 2025.
  56. ^ "Infertility". The Lecturio Medical Concept Library. Archived from the original on 27 August 2021. Retrieved 27 August 2021.
  57. ^ van der Meij, Eva; Emanuel, Mark Hans (January 2016). "Hysterectomy for heavy menstrual bleeding". Women's Health (London, England). 12 (1): 63–69. doi:10.2217/whe.15.87. ISSN 1745-5065. PMC 5779572. PMID 26756830.
  58. ^ Iglesia, Dr Cheryl. "5 Things I Wish All Women Knew About Pelvic Organ Prolapse". www.acog.org. Retrieved 19 August 2025.
  59. ^ "What Is Pelvic Inflammatory Disease?". WebMD. Archived from the original on 24 March 2022. Retrieved 24 April 2022.
  60. ^ "Urinary Tract Infection (UTI)". WebMD. Retrieved 19 August 2025.
  61. ^ "Polycystic Ovary Syndrome (PCOS)". www.hopkinsmedicine.org. Retrieved 19 August 2025.
  62. ^ Goswami, Nidhi; Upadhyay, Kalpana; Briggs, Paula; Osborn, Elizabeth; Panay, Nick (13 November 2022). "Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder". The Obstetrician & Gynaecologist. 25 (1): 38–46. doi:10.1111/tog.12848. ISSN 1744-4667.
  63. ^ a b "Urogynecologist". Cleveland Clinic. Retrieved 19 August 2025.
  64. ^ "MDT team for gynaecological cancers". www.macmillan.org.uk. Retrieved 19 August 2025.
  65. ^ "Obstetrics and Gynecology Specialty Description". American Medical Association. Archived from the original on 28 October 2020. Retrieved 24 October 2020.
  66. ^ Cooper, Danielle B.; Menefee, Gary W. (2025), "Dilation and Curettage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 33760550, retrieved 21 August 2025
  67. ^ Hashemi, Maryam; Madani, Elham S.; Ghahiri, Ataallah; Tarrahi, Mohammad J.; Rouholamin, Safoura (29 July 2024). "Assessment of Long- and Short-Term Outcomes of Hysteroscopic Polypectomy in Patients with Uterine Polyps". Advanced Biomedical Research. 13: 57. doi:10.4103/abr.abr_66_23. ISSN 2277-9175. PMC 11478784. PMID 39411692.
  68. ^ Janda, Monika; Armfield, Nigel R; Kerr, Gayle; Kurz, Suzanne; Jackson, Graeme; Currie, Jason; Page, Katie; Weaver, Edward; Yazdani, Anusch; Obermair, Andreas (25 April 2019). "Patient-Reported Experiences After Hysterectomy: A Cross-Sectional Study of the Views of Over 2300 Women". Journal of Patient Experience. 7 (3): 372–379. doi:10.1177/2374373519840076. ISSN 2374-3735. PMC 7410135. PMID 32821797.
  69. ^ Don, Emma E.; Mijatovic, Velja; van Eekelen, Rik; Huirne, Judith A. F. (November 2023). "The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study". Reproductive Biomedicine Online. 45 (5): 970–978. doi:10.1016/j.rbmo.2022.05.025. ISSN 1472-6491. PMID 36041962.
  70. ^ Minalt, Nicole; Canela, Christinne D.; Marino, Sarah (11 September 2024), "Endometrial Ablation", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29083707, retrieved 21 August 2025
  71. ^ Schwarz, Eleanor Bimla; Lewis, Carrie A.; Dove, Melanie S.; Murphy, Eryn; Zuckerman, Diana; Nunez-Eddy, Claudia; Tancredi, Daniel J.; McDonald-Mosley, Raegan; Sonalkar, Sarita; Hathaway, Mark; Gariepy, Aileen M. (23 February 2022). "Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation". Journal of General Internal Medicine. 37 (16): 4168–4175. doi:10.1007/s11606-022-07433-4. ISSN 1525-1497. PMC 8863411. PMID 35194746.
  72. ^ Vitale, Salvatore Giovanni; Giannini, Andrea; Carugno, Jose; van Herendael, Bruno; Riemma, Gaetano; Pacheco, Luis Alonso; Drizi, Amal; Mereu, Liliana; Bettocchi, Stefano; Angioni, Stefano; Haimovich, Sergio (1 October 2024). "Hysteroscopy: where did we start, and where are we now? The compelling story of what many considered the "Cinderella" of gynecological endoscopy". Archives of Gynecology and Obstetrics. 310 (4): 1877–1888. doi:10.1007/s00404-024-07677-x. ISSN 1432-0711. PMC 11393125. PMID 39150502.
  73. ^ Levy, Lior; Tsaltas, Jim (2021). "Recent advances in benign gynecological laparoscopic surgery". Faculty Reviews. 10: 60. doi:10.12703/r/10-60. ISSN 2732-432X. PMC 8361750. PMID 34409423.
  74. ^ Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML (February 2016). "Imaging modalities for the non-invasive diagnosis of endometriosis". The Cochrane Database of Systematic Reviews. 2016 (2): CD009591. doi:10.1002/14651858.cd009591.pub2. PMC 7100540. PMID 26919512.{{cite journal}}: CS1 maint: article number as page number (link)
  75. ^ Nezhat, Camran; Agarwal, Shruti; Lee, Deborah Ann; Tavallaee, Mahkam (1 June 2022). "Can we accurately diagnose endometriosis without a diagnostic laparoscopy?". Journal of the Turkish German Gynecological Association. 23 (2): 117–119. doi:10.4274/jtgga.galenos.2022.2022-2-2. ISSN 1309-0399. PMC 9161000. PMID 35642436.
  76. ^ Medeiros, L. R.; Stein, A. T.; Fachel, J.; Garry, R.; Furness, S. (May 2008). "Laparoscopy versus laparotomy for benign ovarian tumor: a systematic review and meta-analysis". International Journal of Gynecological Cancer. 18 (3): 387–399. doi:10.1111/j.1525-1438.2007.01045.x. ISSN 1048-891X. PMID 17692084.
  77. ^ "Laparotomy for ovarian cancer". www.cancerresearchuk.org. Retrieved 22 August 2025.
  78. ^ "Recommendations | Urinary incontinence and pelvic organ prolapse in women: management | Guidance | NICE". www.nice.org.uk. 2 April 2019. Retrieved 22 August 2025.
  79. ^ Klebanoff, Jordan S.; Marfori, Cherie Q.; Ingraham, Caitlin F.; Wu, Catherine Z.; Moawad, Gaby N. (August 2019). "Applications of Tranexamic acid in benign gynecology". Current Opinion in Obstetrics & Gynecology. 31 (4): 235–239. doi:10.1097/GCO.0000000000000547. ISSN 1473-656X. PMID 31022078.
  80. ^ Dhamangaonkar, Pallavi C.; Anuradha, K.; Saxena, Archana (2015). "Levonorgestrel intrauterine system (Mirena): An emerging tool for conservative treatment of abnormal uterine bleeding". Journal of Mid-Life Health. 6 (1): 26–30. doi:10.4103/0976-7800.153615. ISSN 0976-7800. PMC 4389381. PMID 25861205.
  81. ^ Lee, SiWon; Stewart, Elizabeth A. (3 May 2023). "New treatment options for nonsurgical management of uterine fibroids". Current Opinion in Obstetrics & Gynecology. 35 (4): 288–293. doi:10.1097/GCO.0000000000000880. ISSN 1473-656X. PMC 10330353. PMID 37144584.
  82. ^ Sidharthan, Dr Chinta (21 March 2025). "Endometriosis Breakthroughs: New Treatments and Research". News-Medical. Retrieved 22 August 2025.
  83. ^ Sufriyana, H., Wu, Y. W., Su, E. C. Y. (2024). Artificial Intelligence–Assisted Gynecology: Emerging Applications and Future Directions. Journal of Clinical Medicine, 13(4), 1061. https://doi.org/10.3390/jcm13041061
  84. ^ Martinelli, Canio; Ercoli, Alfredo; Vizzielli, Giuseppe; Burk, Sharon Raffaella; Cuomo, Maria; Satasiya, Vrunda; Kacem, Housem; Braccia, Simone; Mazzarotti, Giulio; Miriello, Irene; Tchamou, Manuela Nana; Restaino, Stefano; Arcieri, Martina; Poli, Alice; Tius, Veronica (8 May 2025). "Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice". Journal of Experimental & Clinical Cancer Research. 44 (1): 140. doi:10.1186/s13046-025-03371-1. ISSN 1756-9966. PMC 12060497. PMID 40340939.
  85. ^ Dückelmann, A. M., & Maia, L. (2023). vNOTES in Modern Gynecology: A Review of Current Evidence and Outcomes. Healthcare, 13(7), 720. https://doi.org/10.3390/healthcare13070720
  86. ^ "RCOG strategy". RCOG. Retrieved 28 February 2025.
  87. ^ Lundeberg, Kathleen R; Madison, Shannon; Lo, Nancy; Maxwell, Rose; Massengill, Jason (1 November 2024). "Resident Performance on the Obstetrics and Gynecology In-Training Examination After Implementation of a New Academic Curriculum". Cureus. 16 (11): e72861. doi:10.7759/cureus.72861. ISSN 2168-8184. PMC 11610421. PMID 39624527.{{cite journal}}: CS1 maint: article number as page number (link)
  88. ^ Stewart, Chere M. L.; Wheeler, Thomas L.; Markland, Alayne D.; Straughn, J. Michael; Richter, Holly E. (December 2009). "Life-space assessment in urogynecology and gynecological oncology surgery patients: a measure of perioperative mobility and function". Journal of the American Geriatrics Society. 57 (12): 2263–2268. doi:10.1111/j.1532-5415.2009.02557.x. ISSN 1532-5415. PMC 3252022. PMID 19874406.
  89. ^ "What is a Gynecologic Oncologist?". Society of Gynecologic Oncology. Retrieved 19 August 2025.
  90. ^ "What Is a Urogynecologist?". Northwestern Medicine Urogynecology and Reconstructive Pelvic Surgery. Retrieved 19 August 2025.
  91. ^ Groves, Nancy (February 2008). "From Past to Present: The Changing Demographics of Women in Medicine". Ophthalmology Times. American Academy of Ophthalmology.
  92. ^ "Women dominate ob/gyn field but make less money than male counterparts". ScienceDaily (Press release). University of Colorado Anschutz Medical Campus. 1 April 2019.
  93. ^ More, Dr Ashwin (4 December 2013). "Why Are Men Gynaecologists?". Akhandajyoti Multispeciality Hospital, Nashik. Retrieved 24 June 2014.
  94. ^ "Are Male Gynecologists Creepy?". The Daily Beast. 9 December 2013. Archived from the original on 27 June 2014. Retrieved 24 June 2014.
  95. ^ Gerber, Susan E.; Lo Sasso, Anthony T. (November 2006). "The evolving gender gap in general obstetrics and gynecology". American Journal of Obstetrics and Gynecology. 195 (5): 1427–1430. doi:10.1016/j.ajog.2006.07.043. PMID 17074550.
  96. ^ Kornfield, Meryl (9 September 2020). "New York OB/GYN Robert Hadden indicted on federal charges of sexual assault". The Washington Post.
  97. ^ "Gynecologist Loses License After Having Sex With Patients Who Asked About G-Spots Dr. Kurt Froelich assaulted patients in his office and the hospital". 10 February 2015. Archived from the original on 12 November 2020. Retrieved 22 October 2020.
  98. ^ Hall Judith A, Roter Debra L (2 December 2002). "Do patients talk differently to male and female physicians?: A meta-analytic review". Patient Education and Counseling. 48 (3): 217–224. doi:10.1016/S0738-3991(02)00174-X. PMID 12477606.
  99. ^ Schnatz, Peter F.; Murphy, Jessica L.; O’Sullivan, David M.; Sorosky, Joel I. (November 2007). "Patient choice: comparing criteria for selecting an obstetrician-gynecologist based on image, gender, and professional attributes". American Journal of Obstetrics and Gynecology. 197 (5): 548.e1–548.e7. doi:10.1016/j.ajog.2007.07.025. PMID 17980206.
  100. ^ "Career Trends for OB/GYN Physician Jobs". Archived from the original on 17 December 2014. Retrieved 24 June 2014.
  101. ^ "Enhancing the Representation of Women as Senior Leaders in Obstetrics and Gynaecology" (PDF). Archived from the original (PDF) on 17 December 2014. Retrieved 24 June 2014.
  102. ^ "Discrimination against male gynaecologists? Swedish clinics ban women from choosing female doctors". 29 January 2007. Archived from the original on 23 June 2018. Retrieved 24 June 2014.
  103. ^ Trysell, Katrin (11 April 2018). "Byta doktor ingen rättighet" [Switching Doctor Not a Right]. Läkartidningen (in Swedish). Archived from the original on 26 April 2018. Retrieved 25 April 2018.
  104. ^ "Male Gynaecologist in Turkey: Dying profession?". 22 May 2014. Archived from the original on 4 March 2016. Retrieved 25 June 2014.
  105. ^ a b Lewin, Tamar (7 February 2001). "Women's Health Is No Longer a Man's World". The New York Times. Archived from the original on 4 July 2018. Retrieved 14 July 2014.
  106. ^ Sun, Baltimore (2 February 2014). "Nurse questions all-female OB-GYN practice". Archived from the original on 4 April 2014. Retrieved 14 July 2014.
  107. ^ "DAVID A. GARFINKEL, M.D. v. MORRISTOWN OBSTETRICS and GYNECOLOGY ASSOCIATES, P.A., et al". Justia Law. Retrieved 9 August 2023.
  108. ^ "New RCOG research highlights the huge impact of gynaecological conditions on women globally, predominantly in low- and middle-income countries". RCOG. 22 November 2023. Retrieved 19 August 2025.
  109. ^ Jacoby, Vanessa L.; Fujimoto, Victor Y.; Giudice, Linda C.; Kuppermann, Miriam; Washington, A. Eugene (28 April 2010). "Racial and ethnic disparities in benign gynecologic conditions and associated surgeries". American Journal of Obstetrics and Gynecology. 202 (6): 514–521. doi:10.1016/j.ajog.2010.02.039. ISSN 1097-6868. PMC 4625911. PMID 20430357.
  110. ^ a b "Racial and Ethnic Inequities in Obstetrics and Gynecology". www.acog.org. Retrieved 18 April 2025.
  111. ^ a b Chatterjee, Sudeshna; Gupta, Divya; Caputo, Thomas A.; Holcomb, Kevin (2016). "Disparities in Gynecological Malignancies". Frontiers in Oncology. 6: 36. doi:10.3389/fonc.2016.00036. ISSN 2234-943X. PMC 4761838. PMID 26942126.
  112. ^ "Maternal Mortality among Black Women in the United States". Ballard Brief. Retrieved 18 April 2025.
  113. ^ Taouk, Laura H.; Fialkow, Michael F.; Schulkin, Jay A. (2018). "Provision of Reproductive Healthcare to Women with Disabilities: A Survey of Obstetrician-Gynecologists' Training, Practices, and Perceived Barriers". Health Equity. 2 (1): 207–215. doi:10.1089/heq.2018.0014. ISSN 2473-1242. PMC 6110183. PMID 30283869.
  114. ^ Kuper, Hannah; Andiwijaya, Fahrin Ramadan; Rotenberg, Sara; Yip, Jennifer LY (18 April 2024). "Principles for Service Delivery: Best Practices for Cervical Screening for Women with Disabilities". International Journal of Women's Health. 16: 679–692. doi:10.2147/IJWH.S428144. PMID 38650833.
  115. ^ Pickwell-Smith, Benjamin A.; Paton, Lewis W.; Soyiri, Ireneous; Lind, Michael; Macleod, Una (16 February 2025). "Are there inequalities in ovarian cancer diagnosis and treatment in England? A population-based study". Cancer Epidemiology. 96 102778. doi:10.1016/j.canep.2025.102778. ISSN 1877-7821. PMID 40058114.
  116. ^ Scott, Emily C. S.; Hoskin, Peter J. (October 2024). "Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom". The Lancet. 76 102864. doi:10.1016/j.eclinm.2024.102864. ISSN 2589-5370. PMC 11447363. PMID 39364271.
  117. ^ "Pride Month: We all need to strive to provide inclusive healthcare". RCOG. Retrieved 22 August 2025.
  118. ^ Kcomt, Luisa; Gorey, Kevin M.; Barrett, Betty Jo; McCabe, Sean Esteban (August 2020). "Healthcare avoidance due to anticipated discrimination among transgender people: A call to create trans-affirmative environments". SSM - Population Health. 11 100608. doi:10.1016/j.ssmph.2020.100608. ISSN 2352-8273. PMC 7276492. PMID 32529022.
  119. ^ Unger, Cécile A. (January 2014). "Care of the transgender patient: the role of the gynecologist". American Journal of Obstetrics & Gynecology. 210 (1): 16–26. doi:10.1016/j.ajog.2013.05.035. ISSN 0002-9378. PMID 23707806.
  120. ^ Diaz G, A; Moore, S.P.; Martin, J.H.; Green, A.C; Coory, M.; Garvey, G; Valery, P.C. (October 2025). "Early Diagnosis and Improved Treatment Uptake in the First Year may Reduce Survival Disparities between Aboriginal and Torres Strait Islander and other Australian Women Diagnosed with Gynaecological Cancer". International Journal of Epidemiology. 44 (Suppl_1): i87. doi:10.1093/ije/dyv096.004.

Sources

edit
edit
 
Look up gynecology or gynaecology in Wiktionary, the free dictionary.
 
Wikimedia Commons has media related to Gynaecology.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Gynaecology&oldid=1307884018#Diseases"